Gene Symbol | CITED2 |
Entrez ID | 10370 |
Uniprot ID | Q99967 |
Description | Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 |
Chromosomal Location | chr6: 139,371,807-139,374,620 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter |
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IMP |
BP |
GO:0001666 |
response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
IDA|IMP |
BP |
GO:0001889 |
liver development |
The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes. |
ISS |
BP |
GO:0003151 |
outflow tract morphogenesis |
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. |
ISS |
BP |
GO:0003156 |
regulation of animal organ formation |
Any process that modulates the rate, frequency or extent of animal organ formation. Organ formation is the process pertaining to the initial formation of an organ from unspecified parts. The process begins with the specific processes that contribute to the appearance of the discrete structure, such as inductive events, and ends when the structural rudiment of the organ is recognizable, such as a condensation of mesenchymal cells into the organ rudiment. |
ISS |
BP |
GO:0006351 |
transcription, DNA-templated |
The cellular synthesis of RNA on a template of DNA. |
IEA |
BP |
GO:0007368 |
determination of left/right symmetry |
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry. |
ISS |
BP |
GO:0007507 |
heart development |
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
IMP|ISS |
BP |
GO:0007530 |
sex determination |
Any process that establishes and transmits the specification of sexual status of an individual organism. |
IBA|ISS |
BP |
GO:0008283 |
cell proliferation |
The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
IDA |
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IDA |
BP |
GO:0010629 |
negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IDA |
BP |
GO:0022409 |
positive regulation of cell-cell adhesion |
Any process that activates or increases the rate or extent of cell adhesion to another cell. |
ISS |
BP |
GO:0030154 |
cell differentiation |
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
IEA |
BP |
GO:0030336 |
negative regulation of cell migration |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration. |
IMP |
BP |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway |
Any process that activates or increases the frequency, rate or extent of TGF-beta receptor signaling pathway activity. |
ISS |
BP |
GO:0034405 |
response to fluid shear stress |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface. |
IMP |
BP |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway |
Any process that activates or increases the frequency, rate or extent of the peroxisome proliferator activated receptor signaling pathway. |
IDA |
BP |
GO:0035802 |
adrenal cortex formation |
The process that gives rise to the adrenal cortex. This process pertains to the initial formation of a structure from unspecified parts. The adrenogonadal primordium from which the adrenal cortex is formed derives from a condensation of coelomic epithelial cells (the urogenital ridge; the same structure from which gonads and kidney also originate). |
ISS |
BP |
GO:0043066 |
negative regulation of apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
ISS |
BP |
GO:0043627 |
response to estrogen |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
IDA |
BP |
GO:0045787 |
positive regulation of cell cycle |
Any process that activates or increases the rate or extent of progression through the cell cycle. |
ISS |
BP |
GO:0045892 |
negative regulation of transcription, DNA-templated |
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
IDA|IMP |
BP |
GO:0045893 |
positive regulation of transcription, DNA-templated |
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
IDA|ISS |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IDA|ISS |
BP |
GO:0048536 |
spleen development |
The process whose specific outcome is the progression of the spleen over time, from its formation to the mature structure. The spleen is a large vascular lymphatic organ composed of white and red pulp, involved both in hemopoietic and immune system functions. |
ISS |
BP |
GO:0060412 |
ventricular septum morphogenesis |
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another. |
ISS |
BP |
GO:0060971 |
embryonic heart tube left/right pattern formation |
The pattern specification process that results in the subdivision of the left/right axis of the embryonic heart tube in space to define an area or volume in which specific patterns of cell differentiation will take place. |
ISS |
BP |
GO:0060972 |
left/right pattern formation |
The pattern specification process that results in the subdivision of the left/right axis in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment. |
IBA |
BP |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia |
Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus. |
IDA |
BP |
GO:0070986 |
left/right axis specification |
The establishment, maintenance and elaboration of the left/right axis. The left/right axis is defined by a line that runs orthogonal to both the anterior/posterior and dorsal/ventral axes. Each side is defined from the viewpoint of the organism rather of the observer (as per anatomical axes). |
ISS |
BP |
GO:1900164 |
nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, which contributes to the establishment of lateral mesoderm with respect to the left and right halves. |
ISS |
BP |
GO:2000020 |
positive regulation of male gonad development |
Any process that activates or increases the frequency, rate or extent of male gonad development. |
ISS |
CC |
GO:0000790 |
nuclear chromatin |
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus. |
ISS |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IDA |
MF |
GO:0001105 |
RNA polymerase II transcription coactivator activity |
Interacting selectively and non-covalently with an RNA polymerase II (RNAP II) regulatory transcription factor and also with the RNAP II basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between activating transcription factors and the basal RNAP II transcription machinery. |
IBA |
MF |
GO:0001106 |
RNA polymerase II transcription corepressor activity |
Interacting selectively and non-covalently with an RNA polymerase II repressing transcription factor and also with the RNA polymerase II basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery. |
IDA |
MF |
GO:0003682 |
chromatin binding |
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
ISS |
MF |
GO:0003700 |
transcription factor activity, sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
ISS |
MF |
GO:0003713 |
transcription coactivator activity |
Interacting selectively and non-covalently with a activating transcription factor and also with the basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. |
IDA |
MF |
GO:0003714 |
transcription corepressor activity |
Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery. |
IDA|IMP |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0035035 |
histone acetyltransferase binding |
Interacting selectively and non-covalently with the enzyme histone acetyltransferase. |
IDA |
MF |
GO:0050693 |
LBD domain binding |
Interacting selectively and non-covalently with the LBD, the ligand binding domain found in nuclear receptors. In general, the LBDs consist of three layers comprised of twelve alpha-helices and several beta-strands that are organized around a lipophilic ligand-binding pocket. |
IPI |
Domain ID | Description |
---|---|
IPR007576 |
CITED |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04137 |
Mitophagy - animal |
KEGG |
h_pparaPathway |
Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha) |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0018816 |
Heart Septal Defects |
C0026846 |
Muscular Atrophy |
C0039685 |
Tetralogy Of Fallot |
C0344724 |
Ostium Secundum Atrial Septal Defect |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
appendix |
glandular cells |
bone marrow |
hematopoietic cells |
breast |
glandular cells |
bronchus |
respiratory epithelial cells |
caudate |
glial cells |
cerebellum |
cells in molecular layer |
cerebral cortex |
neuronal cells |
cervix, uterine |
glandular cells |
cervix, uterine |
squamous epithelial cells |
colon |
endothelial cells |
colon |
glandular cells |
colon |
peripheral nerve/ganglion |
duodenum |
glandular cells |
endometrium |
glandular cells |
esophagus |
squamous epithelial cells |
fallopian tube |
glandular cells |
gallbladder |
glandular cells |
heart muscle |
myocytes |
hippocampus |
neuronal cells |
kidney |
cells in glomeruli |
kidney |
cells in tubules |
liver |
bile duct cells |
lung |
macrophages |
lung |
pneumocytes |
lymph node |
germinal center cells |
lymph node |
non-germinal center cells |
nasopharynx |
respiratory epithelial cells |
oral mucosa |
squamous epithelial cells |
pancreas |
exocrine glandular cells |
pancreas |
islets of Langerhans |
parathyroid gland |
glandular cells |
placenta |
decidual cells |
placenta |
trophoblastic cells |
prostate |
glandular cells |
rectum |
glandular cells |
salivary gland |
glandular cells |
skeletal muscle |
myocytes |
skin |
epidermal cells |
small intestine |
glandular cells |
soft tissue |
peripheral nerve |
spleen |
cells in red pulp |
spleen |
cells in white pulp |
stomach |
glandular cells |
testis |
cells in seminiferous ducts |
testis |
Leydig cells |
thyroid gland |
glandular cells |
tonsil |
non-germinal center cells |
urinary bladder |
urothelial cells |
vagina |
squamous epithelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
HIF1A |
3091 |
Q16665 |
0.52 |
LHX3 |
8022 |
Q9UBR4 |
0.65 |
CREBBP |
1387 |
Q92793 |
0.73 |
TBP |
6908 |
P20226 |
0.75 |
TFAP2B |
7021 |
Q92481 |
0.87 |
TFAP2A |
7020 |
P05549 |
0.88 |
TFAP2C |
7022 |
Q92754 |
0.88 |
EP300 |
2033 |
Q09472 |
0.97 |
MAPK1 |
5594 |
P28482 |
0.52 |
ELAVL1 |
1994 |
Q15717 |
0.63 |
SMAD2 |
4087 |
Q15796 |
0.63 |
SMAD3 |
4088 |
P84022 |
0.68 |
HNF4A |
3172 |
P41235 |
0.70 |
LHX2 |
9355 |
P50458 |
0.79 |